Monday, March 10, 2025 | 05:32 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Share buyback plan fails to lift Sun Pharma; stock hits over 7-year low

The drugmaker announced that its board will meet on Tuesday, March 17, 2020 to consider the buyback of company's shares

Sun Pharma
Premium

In the past one year, the Sun Pharma's stock price plunged 25 per cent, as compared to 13 per cent decline in the Sensex

SI Reporter Mumbai
Shares of Sun Pharmaceutical Industries dipped 4 per cent to hit an over 7-year low of Rs 342 on the BSE on Friday despite the drug maker announcing that its board will consider the buyback of company's shares next week.

The stock however outperformed the market, as the benchmark S&P BSE Sensex tanked 9.4 per cent to 29,687 points at 09:22 today. The Nifty50 index hit a 10 per cent lower circuit, bringing trading to a halt for 45 minutes as sell-off worsened in the Indian markets.

“The meeting of board of directors of the Company is scheduled

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in